GENT @ 16.28 -95.49% (798 days ago) - zipjet GENT has a single drug in development, defibrotide, but it is going to be successful for this small biotech. The drug has been granted orphan status in the US and EU. ASH in December will present favorable science on the drug. Approval should come in 2008. Stock could be a 3X to 6X by 2009.